Abstract: The present invention relates to uses, methods and compositions for treating immune-mediated glomerulonephritis, such as crescentic glomerulonephritis. More specifically, the invention relates to the use of an EFGR antagonist or of an inhibitor of EGFR or HB-EGF expression for the treatment of said diseases.
Type:
Application
Filed:
October 31, 2006
Publication date:
April 29, 2010
Applicant:
INSERM (Inetitut National de la Sante et la Recherche Medicale )